Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Oesophageal Squamous Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Testing effectiveness (Phase 2)Study completedNCT00258323
What this trial is testing

Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Case Comprehensive Cancer Center 80
Not applicableWithdrawnNCT00499291
What this trial is testing

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors

Who this might be right for
Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07686926
What this trial is testing

Becotatug Vedotin Plus Tislelizumab and Low-Dose Lenvatinib for Advanced Esophageal Squamous Cell Carcinoma, Phase II

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 36
Not applicableLooking for participantsNCT05392413
What this trial is testing

Immune Indicator Model for Predicting Efficacy of PD-1 Monoclonal Antibody

Who this might be right for
Esophageal Squamous Cell CarcinomaPD-1 Inhibitor
Nanfang Hospital, Southern Medical University 200
Testing effectiveness (Phase 2)Looking for participantsNCT06265285
What this trial is testing

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

Who this might be right for
Advanced Esophageal Squamous Cell CarcinomaAdvanced Renal Cell CarcinomaClinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8+28 more
Mayo Clinic 50
Testing effectiveness (Phase 2)UnknownNCT03817658
What this trial is testing

A Phase II Study of SHR-1210 vs Placebo as Consolidation Chemotherapy After Radical Concurrent Chemoradiotherapy in Locally Advanced ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma
The First Affiliated Hospital of Zhengzhou University 725
Testing effectiveness (Phase 2)Looking for participantsNCT06509568
What this trial is testing

Neoadjuvant ChemoRadiotherapy Followed by Immunotherapy and Surgery for Resectable Esophageal Squamous Cell Carcinoma（CRIS-2 Trial）

Who this might be right for
Esophageal Squamous Cell Carcinoma
Zhejiang Cancer Hospital 92
Testing effectiveness (Phase 2)Ended earlyNCT05834543
What this trial is testing

Clinical Trial to Evaluate the Safety and Effectiveness of TQB2618 Injection Combined Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
Advanced Esophageal Squamous Cell Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 34
Early research (Phase 1)Ended earlyNCT04152018
What this trial is testing

Study of PF-06940434 in Patients With Advanced or Metastatic Solid Tumors.

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckRenal Cell CarcinomaOvarian Cancer+8 more
Pfizer 85
Testing effectiveness (Phase 2)Ended earlyNCT02213133
What this trial is testing

Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas

Who this might be right for
Squamous Cell Carcinoma
Karyopharm Therapeutics Inc 45
Large-scale testing (Phase 3)Not Yet RecruitingNCT07417735
What this trial is testing

SYS6010 Versus Chemotherapy in Locally Advanced or Metastatic/Recurrent Esophageal Squamous Cell Carcinoma

Who this might be right for
Locally Advanced/Metastatic/Recurrent ESCC
CSPC Megalith Biopharmaceutical Co.,Ltd. 436
Large-scale testing (Phase 3)Study completedNCT01591135
What this trial is testing

A Phase III Study of Comparing Paclitaxel Plus 5-Fluorouracil Versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 436
Testing effectiveness (Phase 2)Looking for participantsNCT07751055
What this trial is testing

Neoadjuvant Chemoradiotherapy Combined With CTLA-4 Monoclonal Antibody Plus PD-1 Monoclonal Antibody for Locally Advanced Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Sun Yat-sen University 51
Testing effectiveness (Phase 2)UnknownNCT01486992
What this trial is testing

MFOLFIRI Combine With Nimotuzumab Second Line Chemotherapy for Squamous-cell Carcinoma of the Esophagus

Who this might be right for
Advanced Esophageal Carcinoma
Peking University 40
Testing effectiveness (Phase 2)WithdrawnNCT02041819
What this trial is testing

Neoadjuvant Chemotherapy of Nimotuzumab Plus Nab-Paclitaxel in Squamous Cell Carcinoma of Esophagus

Who this might be right for
Squamous Cell Carcinoma of Esophagus
Zhejiang University
Early research (Phase 1)Study completedNCT06549816
What this trial is testing

SGN-B6A in Chinese Participants With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small Cell LungSquamous Cell Carcinoma of Head and NeckEsophageal Squamous Cell Carcinoma+3 more
Seagen, a wholly owned subsidiary of Pfizer 6
Testing effectiveness (Phase 2)Study completedNCT02133612
What this trial is testing

Adjuvant Chemotherapy With Paclitaxel and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Cancer
Chinese Academy of Medical Sciences 43
Testing effectiveness (Phase 2)UnknownNCT00816634
What this trial is testing

Efficacy Comparison Study of Combination Regimens to Treat Advanced Esophageal Squamous Cell Carcinoma

Who this might be right for
First Line ChemotherapyCapecitabine Plus Cisplatin Versus Capecitabine Plus PaclitaxelAdvanced or Recurrent Esophageal Squamous Cell Carcinoma
Samsung Medical Center 94
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06588335
What this trial is testing

BTLA Inhibitor (JS004) Combined with Toripalimab and Chemotherapy in the Perioperative Treatment of Resectable Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Henan Provincial People's Hospital 20
Next Page